Depreciation, Depletion and Amortization of Lexaria Bioscience Corp. from 31 Aug 2024 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Lexaria Bioscience Corp. quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 31 Aug 2024 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Depreciation, Depletion and Amortization for the quarter ending 30 Nov 2025 was $12,009, a 37% increase year-over-year.
  • Lexaria Bioscience Corp. annual Depreciation, Depletion and Amortization for 2025 was $51,225, a 21% increase from 2024.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

Lexaria Bioscience Corp. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $12,009 +$3,275 +37% 01 Sep 2025 30 Nov 2025 10-Q 13 Jan 2026 2026 Q1
Q4 2024 $8,734 01 Sep 2024 30 Nov 2024 10-Q 10 Jan 2025 2025 Q1

Lexaria Bioscience Corp. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $51,225 +$8,777 +21% 01 Sep 2024 31 Aug 2025 10-Q 13 Jan 2026 2026 Q1
2024 $42,448 01 Sep 2023 31 Aug 2024 10-K 28 Nov 2025 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.